GRFS
HEALTHCAREGrifols SA
$8.41+0.14 (+1.69%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving GRFS Today?
No stock-specific AI insight has been generated for GRFS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$6.97$10.96
$8.41
Fundamentals
Market Cap$5.7B
P/E Ratio12.2
EPS$0.69
Dividend Yield0.02%
Dividend / Share—
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume354K
Avg Volume (10D)—
Shares Outstanding680.6M
GRFS News
21 articles- Grifols Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Grifols shares slide 4% as margin miss soured Q1 profit jumpYahoo Finance·May 7, 2026
- Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsightYahoo Finance·May 4, 2026
- European Equities Traded in the US as American Depositary Receipts Start Week LowerYahoo Finance·May 4, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Thursday TradingYahoo Finance·Apr 30, 2026
- Is Grifols (BME:GRF) A Potential Opportunity After A 59% Five Year Share Price SlideYahoo Finance·Apr 28, 2026
- Kawasaki Disease Market Analysis and Global Forecast Report 2025-2035 Featuring Prominent Players - Takeda Pharmaceutical, CSL Behring, Grifols, ADMA Biologics, and OctapharmaYahoo Finance·Apr 23, 2026
- Grifols (GRFS) Unveils AI-Driven Data for Early Parkinson’s Disease DetectionYahoo Finance·Apr 19, 2026
- Health Canada Imposes New Conditions on Grifols, S.A. (GRFS) Plasma Collection CentersYahoo Finance·Apr 17, 2026
- Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns?Yahoo Finance·Apr 16, 2026
- ADMA Crashes 42.5% YTD: Right Time to Buy the Stock?Yahoo Finance·Apr 15, 2026
- European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday TradingYahoo Finance·Apr 15, 2026
- European Equities Traded in the US as ADRs Rise in Tuesday TradingYahoo Finance·Apr 14, 2026
- Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived DiscountYahoo Finance·Apr 11, 2026
- European Equities Traded in the US as American Depositary Receipts Rise in Friday TradingYahoo Finance·Apr 10, 2026
- Is ADMA Poised for Margin Growth and Supply Expansion in 2026?Yahoo Finance·Apr 10, 2026
- European Equities Traded in the US as American Depositary Receipts Decline in Thursday TradingYahoo Finance·Apr 9, 2026
- European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday TradingYahoo Finance·Apr 7, 2026
- Sector Update: Health Care Stocks Softer Late AfternoonYahoo Finance·Apr 2, 2026
- Sector Update: Health Care Stocks Softer Thursday AfternoonYahoo Finance·Apr 2, 2026
- Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocatesGlobeNewswire Inc.·Mar 30, 2026
All 21 articles loaded
Price Data
Open$8.40
Previous Close$8.27
Day High$8.46
Day Low$8.30
52 Week High$10.96
52 Week Low$6.97
52-Week Range
$6.97$10.96
$8.41
Fundamentals
Market Cap$5.7B
P/E Ratio12.2
EPS$0.69
Dividend Yield0.02%
Dividend / Share—
ROE0.1%
Profit Margin0.1%
Debt / Equity—
Trading
Volume354K
Avg Volume (10D)—
Shares Outstanding680.6M
About Grifols SA
Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
HEALTHCAREDRUG MANUFACTURERS - GENERAL
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - GENERAL
CIK—
Composite FIGI—
Share Class FIGI—